TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tristel ( (GB:TSTL) ) has shared an announcement.
Tristel plc announced that the American Institute of Ultrasound in Medicine has updated its guidelines to include chlorine dioxide as an accepted option for high-level disinfection of ultrasound probes. This inclusion marks a significant milestone for Tristel’s ULT™ foam product, which is the only FDA-cleared chlorine dioxide foam disinfectant for ultrasound probes in the US market, manufactured and distributed by Parker Laboratories under an exclusive partnership. The update, alongside the national standard recognition, is expected to accelerate the adoption of Tristel ULT™ in the US, benefiting clinicians, infection-prevention teams, and hospital administrators.
The most recent analyst rating on (GB:TSTL) stock is a Buy with a £420.00 price target. To see the full list of analyst forecasts on Tristel stock, see the GB:TSTL Stock Forecast page.
Spark’s Take on GB:TSTL Stock
According to Spark, TipRanks’ AI Analyst, GB:TSTL is a Outperform.
Tristel’s overall stock score of 74 is primarily driven by strong financial performance and positive corporate events, such as strategic expansions and new product launches. However, bearish technical indicators and a high valuation limit the score. The robust financial health and strategic initiatives position Tristel well for future growth, although current market sentiment and valuation warrant caution.
To see Spark’s full report on GB:TSTL stock, click here.
More about Tristel
Tristel plc is a global infection prevention company specializing in the manufacture and supply of products utilizing its proprietary chlorine dioxide chemistry. The company is a leader in manual decontamination of medical devices, providing hospitals with products under the Tristel brand and offering sporicidal surface disinfection solutions under the Cache brand. Tristel operates globally with a head office in Snailwell, near Cambridge, and employs approximately 270 people across 16 subsidiaries, selling in over 40 countries. The company aims for double-digit revenue growth annually, maintains a profitable operation with no debt, and has a progressive dividend policy. It has been listed on the London Stock Exchange’s AIM market since 2005.
Average Trading Volume: 189,524
Technical Sentiment Signal: Sell
Current Market Cap: £169.5M
See more insights into TSTL stock on TipRanks’ Stock Analysis page.